Detalles de la búsqueda
1.
In Vitro Activity of Tebipenem against Various Resistant Subsets of Escherichia coli Causing Urinary Tract Infections in the United States (2018 to 2020).
Antimicrob Agents Chemother
; 66(10): e0121422, 2022 10 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-36169327
2.
Updated Prevalence of mcr-Like Genes among Escherichia coli and Klebsiella pneumoniae in the SENTRY Program and Characterization of mcr-1.11 Variant.
Antimicrob Agents Chemother
; 63(4)2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30917984
3.
Recent increase in fluconazole-nonsusceptible Candida parapsilosis in a global surveillance with the expansion of the Erg11 Y132F genotype and a rapid detection method for this alteration.
Diagn Microbiol Infect Dis
; 106(3): 115957, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-37167652
4.
Vaborbactam increases meropenem susceptibility in Pseudomonas aeruginosa clinical isolates displaying MexXY and AmpC upregulation.
mSphere
; 8(5): e0016223, 2023 10 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-37768064
5.
The plethora of resistance mechanisms in Pseudomonas aeruginosa: transcriptome analysis reveals a potential role of lipopolysaccharide pathway proteins to novel ß-lactam/ß-lactamase inhibitor combinations.
J Glob Antimicrob Resist
; 31: 72-79, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35931381
6.
Ceftazidime-avibactam activity against a challenge set of carbapenem-resistant Enterobacterales: Ompk36 L3 alterations and ß-lactamases with ceftazidime hydrolytic activity lead to elevated MIC values.
Int J Antimicrob Agents
; 56(1): 106011, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-32417206
Resultados
1 -
6
de 6
1
Próxima >
>>